Skip to main content
Equibles

VANGUARD ASSET MANAGEMENT, Ltd

Position in NEO — Neogenomics Inc

CIK 1680208 London, EC4N 8AF, X0
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,403,353
+$818,227 QoQ
Shares Held
96,186
+22.0% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

VANGUARD ASSET MANAGEMENT, Ltd holds $1,276,566,540 across 30 Diagnostics & Research names. NEO ranks #22 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 729,800 $365,892,528
2 DHR
Danaher Corp /De/
 1,222,312 $232,825,989
3 IDXX
Idexx Laboratories Inc /De
 155,306 $81,759,290
4 A
Agilent Technologies, Inc.
 548,583 $72,868,279
5 NTRA
Natera, Inc.
 262,485 $71,251,553
6 WAT
Waters Corp /De/
 189,305 $70,996,947
7 IQV
Iqvia Holdings Inc.
 333,682 $64,474,036
8 MTD
Mettler Toledo International Inc/
 42,093 $53,774,228

All Filings in NEO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,403,353 96,186
2026-03-31 $585,126 78,858